JPRN-UMIN000004208
Completed
未知
The exploratory study of F-18 FAZA PET/CT for patients with non-small cell lung cancer - FAZA PET/CT tests for patients with lung cancer
ational Cancer Center0 sites30 target enrollmentSeptember 15, 2010
Conditionson-small cell lung cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- on-small cell lung cancer
- Sponsor
- ational Cancer Center
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) The case who is difficult to be included in the study due to psychological disorder and so on. 2\) The case to whom the test agent cannot be injected due to iodine allergy and so on. 3\) The case who is judged by the physician in charge not to be included in the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Exploratory Study of Usefulness of 18F-BPA PET/CT in Clinical Staging of Malignanciespatients with malignanciesJPRN-UMIN000008359"Hotta Group" of National Cancer Center Cancer Research and Development Fund120
Completed
Not Applicable
A retrospective study using 18F-FDG-PET/CT for the prediction of immunotherapy-related interstitial lung disease in lung cancer.Advanced or recurrent lung cancerJPRN-UMIN000053550iigata University Medical and Dental Hospital165
Withdrawn
Phase 2
18F-CP18 Imaging Studies for Cancer Treatment With BirinapantOvarian NeoplasmsOvarian CancerFallopian Tube NeoplasmsFallopian Tube CancerNCT01766622National Institutes of Health Clinical Center (CC)
Completed
Phase 3
A Prospective Study on 18F-DCFPyL PET/CT Imaging in Biochemical Recurrence of Prostate CancerBiochemical recurrent prostate cancerprostate cancer10014713NL-OMON55231Curium PET France30
Active, not recruiting
Phase 1
A Study on PET/CT Imaging (scan) with 18F-DCFPyL (radioactive substance) of Prostate Cancer having recurred shown by increase in PSA blood levelPatients with histopathologically confirmed prostate adenocarcinoma per original diagnosis and subsequent definitive therapy, with first biochemical recurrenceMedDRA version: 21.0Level: PTClassification code 10036911Term: Prostate cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2020-000121-37-FRCYCLOPHARMA217